Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety of Simvastatin (SOS) in Patients With Pulmonary Lymphangioleiomyomatosis (LAM) and With Tuberous Sclerosis Complex (TSC)

NCT02061397 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT02061397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02061397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety of Simvastatin (SOS) in Patients With Pulmonary Lymphangioleiomyomatosis (LAM) and With Tuberous Sclerosis Complex (TSC)
Lead sponsor
University of Pennsylvania
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2014
Completion date
December 13, 2019
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphangioleiomyomatosis, tuberous sclerosis complex